The patentability of human embryonic stem cell technology in China

Yaojin Peng*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.
Original languageEnglish
Pages (from-to)37-39
Number of pages3
JournalNature Biotechnology
Issue number1
Early online date8 Jan 2016
Publication statusPublished - Jan 2016

Cite this